Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosfomycin vs ciprofloxacin for prophylaxis in transrectal prostate biopsy
2017-000772-28Phase 2Completed
- Sponsor
- Johan Styrke
- Start
- Mar 2017
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in sepsis comparing Fosfomycin prophylaxis with Ciprofloxacin prophylaxis (2 arms). Primary endpoint: Submission to inpatient care because of sepsis within two weeks after biopsy. Started Mar 2017; status: completed.
02
Drugs
fosfomycinciprofloxacin
03
Conditions
sepsis
Beyond the preview
Go deeper on 2017-000772-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000772-28.